Philippe Quittet

BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone

Jérôme Moreaux, Éric Legouffe, Éric Jourdan et al. · Blood · 2003 · 559 citations · Full text

A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies

Harriet S. Walter, Simon A. Rule, Martin J.S. Dyer et al. · Blood · 2015 · 262 citations · Full text

PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study

Olivier Casasnovas, Réda Bouabdallah, Pauline Brice et al. · The Lancet Oncology · 2019 · 201 citations · Full text

Pet-adapted Treatment, Lymphoid Neoplasia, Medicine +5

High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years

Emmanuel Gyan, Charles Foussard, Philippe B. Bertrand et al. · Blood · 2008 · 153 citations

Preparation and successful engraftment of purified CD34+ bone marrow progenitor cells in patients with non-Hodgkin's lymphoma

NC Gorin, M. Lopez, J R Laporte et al. · Blood · 1995 · 119 citations · Full text